Literature DB >> 30525245

Construction and analysis of dysregulated lncRNA-associated ceRNA network in colorectal cancer.

Yiping Zhu1,2, Yinzhu Bian3, Qun Zhang4, Jing Hu4, Li Li4, Mi Yang4, Hanqing Qian4, Lixia Yu4, Baorui Liu1,4, Xiaoping Qian1,4.   

Abstract

Colorectal cancer (CRC) is one of the most frequently diagnosed digestive system cancer. The aim of the present study was to investigate the interactions among messenger RNAs (mRNAs), microRNAs (miRNAs), and long noncoding RNAs (lncRNAs) in CRC to reveal the mechanisms of CRC. Differentially expressed genes (DEGs) were identified from public gene expression data sets. One thousand eighty-one common dysregulated mRNAs in two data sets were identified. Gene function analysis and protein-protein interaction network analysis indicated that these DEGs might play important roles in CRC. LINC00365 was selected through coding- noncoding network analysis and its expression was validated upregulated in 22 paired clinical samples and four CRC cell lines. A competing endogenous RNA network composed of 70 miRNAs, nine mRNAs, and LINC00365 was constructed. Eight of nine mRNAs were validated upregulated in The Cancer Genome Atlas data set. Our results suggested that LINC00365 was an oncogene in CRC and it could regulate the expression of several mRNAs through sponging miRNAs.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  bioinformatics analysis; colorectal cancer; competing endogenous RNA; long noncoding RNA; weighted gene corepression analysis

Mesh:

Substances:

Year:  2018        PMID: 30525245     DOI: 10.1002/jcb.28201

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  10 in total

1.  Genome-Wide Analysis of the FOXA1 Transcriptional Network Identifies Novel Protein-Coding and Long Noncoding RNA Targets in Colorectal Cancer Cells.

Authors:  Sarah B Lazar; Lorinc Pongor; Xiao Ling Li; Ioannis Grammatikakis; Bruna R Muys; Emily A Dangelmaier; Christophe E Redon; Sang-Min Jang; Robert L Walker; Wei Tang; Stefan Ambs; Curtis C Harris; Paul S Meltzer; Mirit I Aladjem; Ashish Lal
Journal:  Mol Cell Biol       Date:  2020-10-13       Impact factor: 4.272

2.  Identification of novel survival-related lncRNA-miRNA-mRNA competing endogenous RNA network associated with immune infiltration in colorectal cancer.

Authors:  Jianxin Li; Ting Han; Xin Wang; Yinchun Wang; Qingqiang Yang
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

3.  Integration analysis of long non-coding RNA (lncRNA) role in tumorigenesis of colon adenocarcinoma.

Authors:  Arash Poursheikhani; Mohammad Reza Abbaszadegan; Negin Nokhandani; Mohammad Amin Kerachian
Journal:  BMC Med Genomics       Date:  2020-07-29       Impact factor: 3.063

4.  A Novel Circular RNA, circ_0005394, Predicts Unfavorable Prognosis and Contributes to Hepatocellular Carcinoma Progression by Regulating miR-507/E2F3 and miR-515-5p/CXCL6 Signaling Pathways.

Authors:  Chengming Sun; Guodong Li; Ming Liu
Journal:  Onco Targets Ther       Date:  2020-06-29       Impact factor: 4.147

5.  Identification and Validation of an Immune-Related RNA Signature to Predict Survival of Patients With Head and Neck Squamous Cell Carcinoma.

Authors:  Shuo Wu; Xinyi Dai; Dielai Xie
Journal:  Front Genet       Date:  2019-12-04       Impact factor: 4.599

6.  Comprehensive analysis of ceRNA network of ERCC4 in colorectal cancer.

Authors:  Huixin Hu; Songyi Liu; Aining Chu; Jing Chen; Chengzhong Xing; Jingjing Jing
Journal:  PeerJ       Date:  2021-12-14       Impact factor: 2.984

7.  LncRNA HCG18 upregulates TRAF4/TRAF5 to facilitate proliferation, migration and EMT of epithelial ovarian cancer by targeting miR-29a/b.

Authors:  Fan Zhang; Bai-Hua Luo; Qi-Hui Wu; Qing-Ling Li; Ke-Da Yang
Journal:  Mol Med       Date:  2022-01-04       Impact factor: 6.354

8.  Identification of Novel Biomarkers for Predicting Prognosis and Immunotherapy Response in Head and Neck Squamous Cell Carcinoma Based on ceRNA Network and Immune Infiltration Analysis.

Authors:  Ya Guo; Wei Kang Pan; Zhong Wei Wang; Wang Hui Su; Kun Xu; Hui Jia; Jing Chen
Journal:  Biomed Res Int       Date:  2021-12-06       Impact factor: 3.411

9.  Systematic Pan-Cancer Analysis Identifies CDK1 as an Immunological and Prognostic Biomarker.

Authors:  Yaqi Yang; Qin Liu; Xiyuan Guo; Qing Yuan; Siji Nian; Pengyuan Kang; Zixi Xu; Lin Li; Yingchun Ye
Journal:  J Oncol       Date:  2022-08-31       Impact factor: 4.501

10.  Inhibition of CDK1 Reverses the Resistance of 5-Fu in Colorectal Cancer.

Authors:  Yiping Zhu; Kai Li; Jieling Zhang; Lu Wang; Lili Sheng; Liang Yan
Journal:  Cancer Manag Res       Date:  2020-11-04       Impact factor: 3.989

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.